Commonly referred to as the ‘Chanel Injection’ NCTF® 135HA is a specialised injectable treatment engineered to redensify mature or lax skin and correct superficial fine lines. Rather than acting as a traditional filler, it works through biorevitalisation—a process that restores the skin's biological environment to a more youthful state.

The treatment utilises precise intradermal microinjections to deliver a potent formula directly into the superficial dermis. By bypassing the surface barrier, these active compounds reach the fibroblasts—the ‘factory’ cells responsible for synthesising the collagen and elastin that provide the skin its structure and bounce.

The efficacy of the ‘Chanel Injection’ lies in its synergistic blend: 5mg/mL of non-crosslinked hyaluronic acid paired with a complex of 59 active nutrients. This high-performance cocktail includes 12 vitamins, 24 amino acids, 6 co-enzymes, and 6 minerals, providing a complete ‘nutrient buffet’ to fuel cellular repair.

Key Therapeutic Benefits

• Dermal Redensification: By triggering neocollagenesis, the treatment physically increases skin density and restores lost elasticity.

• Deep Exogenous Hydration: The non-crosslinked HA acts as a potent humectant, holding up to 1,000 times its weight in water to deeply hydrate the extracellular matrix.

• Advanced Antioxidant Protection: Potent ingredients like Glutathione and Vitamins C and E neutralise free radicals, effectively mitigating oxidative stress and slowing the cellular ageing process.

Standard Treatment Protocol

To achieve and sustain these therapeutic outcomes, a typical protocol consists of three sessions spaced three weeks apart. Following this initial ‘loading phase,’ maintenance treatments are recommended every three to six months to preserve dermal quality and long-term radiance.